Anakinra in the Management of COVID-19 Infection

Clinical trial NCT04643678 · COMPLETED

Trial details

NCT number: NCT04643678
Sponsor: Hamad Medical Corporation
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Covid19 Pneumonia Cytokine Release Syndrome Corona Virus Infection Viral Infection

Start date: 2020-10-30
Primary completion: 2021-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.